Michael Geißler
Impact in
- Hepatology top 1%
- Hepatitis C virus research
- Hepatocellular Carcinoma Treatment and Prognosis
- Oncology top 2%
- Colorectal Cancer Treatments and Studies
- Pancreatic and Hepatic Oncology Research
Papers in
- Hepatology 37
- Hepatocellular Carcinoma Treatment and Prognosis 18
- Oncology 93
- Colorectal Cancer Treatments and Studies 49
- Pancreatic and Hepatic Oncology Research 29
- Co-authors
- Jack R. WandsHubert E. BlumKatsutoshi TokushigeLeonhard MohrJens EnckeThomas SeufferleinJasper zu PutlitzVolker Heinemann
- Journals
- Journal of Clinical Oncology (31 papers)Annals of Oncology (16 papers)The Journal of Immunology (6 papers)Hepatology (6 papers)Gastroenterology (5 papers)
- Partner nations
- GermanyUnited StatesFrance
In The Last Decade
Michael Geißler
144 papers receiving 3.4k citations
Peers
Comparison fields: 5 of 119
- Hepatology 755
- Oncology 1.5k
- Immunology 818
- Gastroenterology 150
- Pulmonary and Respiratory Medicine 785
Countries citing papers authored by Michael Geißler
This map shows the geographic impact of Michael Geißler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Geißler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Geißler more than expected).
Fields of papers citing papers by Michael Geißler
This network shows the impact of papers produced by Michael Geißler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Geißler. The network helps show where Michael Geißler may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Geißler, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2023 | 4 | |
| 3 | 2021 | 8 | |
| 4 | 2021 | 1 | |
| 5 | 2020 | 1 | |
| 6 | 2020 | 2 | |
| 7 | 2018 | 0 | |
| 8 | 2017 | 25 | |
| 9 | 2013 | 1 | |
| 10 | 2012 | 77 | |
| 11 | 2009 | 37 | |
| 12 | Cetuximab with irinotecan/NA-FA/5-FU as first-line treatment in advanced gastric cancer: Preliminary results of a non-randomised multi-centre AIO phase II study | 2008 | 8 |
| 13 | 2007 | 59 | |
| 14 | Tyrosinkinaseinhibitoren in der Tumortherapie - Teil 2 | 2005 | 1 |
| 15 | 2005 | 104 | |
| 16 | 2004 | 221 | |
| 17 | 2001 | 30 | |
| 18 | 2001 | 51 | |
| 19 | Genetic immunization generates cellular and humoral immune responses against the nonstructural proteins of the hepatitis C virus in a murine model. | 1998 | 84 |
| 20 | 1998 | 36 |
About Michael Geißler
Michael Geißler is a scholar working on Hepatology, Oncology, Pulmonary and Respiratory Medicine, Immunology and Gastroenterology, having authored 151 papers that have together received 3.5k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (49 papers), Gastric Cancer Management and Outcomes (35 papers), Pancreatic and Hepatic Oncology Research (29 papers), Hepatitis B Virus Studies (22 papers), Lung Cancer Treatments and Mutations (22 papers), Immunotherapy and Immune Responses (20 papers), Hepatocellular Carcinoma Treatment and Prognosis (18 papers) and Cancer Genomics and Diagnostics (15 papers). The work is most often cited by research in Hepatology (755 citations), Oncology (1.5k citations), Immunology (818 citations), Gastroenterology (150 citations) and Pulmonary and Respiratory Medicine (785 citations). Michael Geißler has collaborated with scholars based in Germany, United States and France. Frequent co-authors include Jack R. Wands, Hubert E. Blum, Katsutoshi Tokushige, Leonhard Mohr, Jens Encke, Thomas Seufferlein, Jasper zu Putlitz, Volker Heinemann, Jan Harder and Christian Grimm. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, The Journal of Immunology, Hepatology and Gastroenterology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.